✦ LIBER ✦

Gemcitabine + vinorelbine (GV) yields better survival than vinorelbine (V) alone in elderly non-small cell lung cancer (NSCLC) patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

✍ Scribed by Frasci, G; Lorusso, V; Panza, N; Comella, P; De Cataldis, G; Micillo, E; Iannelli, N; Filippelli, G; Muci, D; Piantedosi, F.V; Belli, M; Nicolella, G.P; Mascia, V; Massidda, B; Comella, G; De Lena, M

Book ID: 118569730
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 118 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80185-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus vinorelbine yields bett

Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial

✍ Frasci, Giuseppe; Lorusso, Vito; Panza, Nicola; Comella, Pasquale; Nicolella, Gi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Gemcitabine + vinorelbine (GV) vs vinore

Gemcitabine + vinorelbine (GV) vs vinorelbine (V) alone in elderly or frail non-small cell lung cancer (NSCLC) patients. Interim analysis of a SICOG phase III trial

✍ G. Frasci; V. Lorusso; N. Panza; G. DeCataldis; F. Del Gaizo; G.P. Nicolella; V. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Cisplatin-gemcitabine, vs. cisplatin-gem

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

✍ Comella, P; Frasci, G; Panza, N; Nicolella, G; Manzione, L; De Cataldis, G; Ciof 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Interim Analysis of a Phase III Trial Co

Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group Study

✍ Pasquale Comella; Nicola Panza; Luigi Manzione; Giuseppe De Cataldis; Riccardo C 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB

Cisplatin/gemcitabine (CG) vs cisplatin/

Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (gv/iv) in advanced non-small cell lung cancer (NSCLC): final results of a Spanish lung cancer group phase III trial (GEPC/98-02)

✍ C. Camps; V. Alberola; M. Provencio; D. Isla; R. Rosell; C. Vadell; I. Bover; A. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

P.40 Oral vinorelbine and gemcitabine (o

P.40 Oral vinorelbine and gemcitabine (oVG) versus docetaxel and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis for elderly patients of a phase III randomized trial from the Hellenic Oncology Research Group (HORG)

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Agelidou, A.; Kotsakis, A.; Kakolyri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB